Hepatitis B DNA vaccine (GENimmune)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis B DNA vaccine (GENimmune)
Drug Alias NameHepatitis B Virus polyepitope vaccine candidate-GENimmuneEP 2210EP-HBSGCR 3697INNO 102 +[9] 
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsHepatitis B virus
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenencorPharmexa-Epimmune
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFujirebio IncGenencorPharmexa-Epimmune
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A